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Abstract
Introduction. We have previously observed that rat synovial membranes incubated in medium containing cartilage 
interstitial fluid (CIF) responded by changes in the expression of hyaluronan synthases (HAS1 and HAS2), colla-
gen type I, versican, aggrecan, lubricin, matrix metalloproteinases 2 and 3 (MMP2 and MMP3), tissue inhibitors 
of metalloproteinases (TIMP1, 2 and 3), transforming growth factor b1 (TGFb1), tumor necrosis factor (TNF), 
interleukin (IL) 1b and IL-6. The aim of the study was to evaluate the influence of particular cytokines found in 
CIF on the gene expression of extracellular matrix (ECM) proteins in synovial membrane cells. 
Material and methods. Synovial membranes (SMs) were removed from the knee joints of inbred, male Lewis 
rats and incubated with insulin-like growth factor 1 (IGF1), TGFb1, basic fibroblast growth factor (bFGF) and 
granulocyte- macrophage colony-stimulating factors (G-CSF and M-CSF), either individually or in the com-
binations TGFb1/IGF1, TGFb1/IGF1/bFGF or G-CSF/M-CSF. Next, total RNA was isolated and the studied 
genes’ expression was evaluated by real-time PCR.
Results. TGFb1/IGF1 stimulated expression of HAS1, lubricin, collagen type I, aggrecan and TGFb1, inhibited 
expression of MMP3 and TNF and had no effect on TIMP1 and IL-6 mRNA levels. TGFb1/IGF1/bFGF stimu-
lated the expression of HAS1, lubricin and TGFb1 genes, inhibited the expression of TNF and had no effect of 
the expression of collagen 1, aggrecan, MMP3, TIMP1 and IL-6 genes. G-CSF/M-CSF stimulated the expression 
of aggrecan. TGFb1, bFGF, and IGF1 applied individually exerted inhibitory effect on the expression of lubricin. 
TGFb1 and bFGF inhibited expression of MMP3 and bFGF inhibited also the expression of aggrecan and TNF.
Conclusions. The response of the studied genes represents a resultant activity of all major cell types building the 
synovial membrane, i.e. highly specialized synovial fibroblasts, macrophages, epithelial cells and adipocytes. The 
results of our study can improve understanding of synovial membrane responses to the intraarticular injections 
of platelet-rich plasma (PRP) used for the treatment of joint ailments, since PRP contains factors which are also 
present in CIF. (Folia Histochemica et Cytobiologica 2016, Vol. 54, No. 3, 159–165)
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Introduction
Articular cartilage has the unique mechanical prop-
erty of being able to withstand compressive loads. 
This ability is attributed to the association between 
type II collagen fibrils, decorin and biglycan, which 
form a network that surrounds and restrains the very 
large, highly hydrated aggregates of the proteoglycan 
aggrecan [1]. Chondrocytes produce not only ma-
trix components, but also numerous cytokines and 
growth factors [2, 3]. Synovial membrane is formed 
by four main types of cells, i.e. highly specialized 
synovial fibroblasts, macrophages, epitheliocytes and 
adipocytes. Functional and metabolic interaction be-
tween articular cartilage and synovial membrane is, 
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however, poorly characterized. Cells of the synovial 
membrane may respond to joint loading producing 
humoral factors such as growth factors, cytokines 
and enzymes which can be released into the synovial 
fluid [4]. Indeed, synoviocytes secrete factors inducing 
synthesis of metalloproteinases by chondrocytes [5] 
and normal synovial fluid contains proteoglycan-de-
grading enzymes [4]. Synovial fluid stimulates also 
collagen type II, glycosaminoglycan and proteoglycan 
synthesis in articular cartilage [6]. Hyaluronic acid 
and lubricin produced by synovial membrane par-
ticipate in articular cartilage lubrication [7]. On the 
other hand, during joint loading about 10% of liquid 
present in cartilage is squeezed and contributes to the 
hydrostatic lubrication of the articular surfaces [8, 9]. 
Since chondrocytes produce numerous growth factors, 
these factors could be present in the liquid released 
from loaded cartilage. Thus, synovial fluid probably 
contains a mixture of factors produced by synovial 
membrane and articular cartilage cells. Van de Lest 
et al. [4] found that the synovial fluid collected from 
ponies after they had been exercised for a week con-
tained increased level of IGF1 in comparison with 
that obtained after a period of box rest but it was not 
established whether IGF1 was produced by synovium, 
articular chondrocytes, or both. 
We have previously harvested cartilage interstitial 
fluid (CIF) from cartilages of young rats and evalu-
ated its influence on gene expression in the synovial 
membrane [10]. Using ELISA assays we detected in 
CIF the presence of seven cytokines: basic fibroblast 
growth factor (bFGF), insulin-like growth factor 1 
(IGF1), transforming growth factor b1 (TGFb1), 
bone morphogenetic protein 7 (BMP7), macrophage 
colony-stimulating factor (M-CSF), granulocyte 
colony-stimulating factor (G-CSF) and leukemia 
inhibitory factor (LIF). CIF stimulated expression 
of hyaluronan synthases 1 and 2 (HAS1 and HAS2), 
collagen type I, versican, aggrecan, lubricin, matrix 
metalloproteinases 2 and 3 (MMP2 and MMP3), 
tissue inhibitors of metalloproteinases 1, 2 and 3 
(TIMP1, TIMP2 and TIMP3), transforming growth 
factor b1 (TGFb1) and interleukin 6 (IL-6), while the 
expression of tumor necrosis factor (TNF) and inter-
leukin 1b (IL-1b) was inhibited. Composition of all 
factors detected in CIF (CIF-like cocktail) stimulated 
expression of HAS1, lubricin, collagen type I, aggre-
can, TIMP1 and TGFb1, but contrary to CIF, did not 
change the expression of MMP-3, IL-6 and TNF [10]. 
In the present work we analyzed the effects of par-
ticular growth factors detected in CIF, either used 
alone or in combination, to establish which of them 
exert the strongest effect on the gene expression of 
ECM proteins in cultured synovial membrane cells.
Material and methods
Animals. Synovial membranes (SMs) were removed from 
the knee joints of specific pathogen-free, inbred, male Lewis 
rats (n = 42; 3 month-old) purchased from the Animal 
Unit of the Mossakowski Medical Research Centre at the 
Polish Academy of Sciences (Warsaw, Poland). The present 
study and the methods were approved by the Animal Ethics 
Committee of the Medical University of Warsaw (Warsaw, 
Poland).
Preparation of rat synovial membranes. Rats were eutha-
nized by inhalation of halothane. After opening the knee 
joint cavity, the SM was excised together with the patella, 
the patellar ligament and the joint capsule. The SM with 
the infrapatellar fat pad was then separated from the other 
tissues according to the method described previously [11]. 
Incubation of synovial membrane. As a standard procedure 
dissected SMs were incubated in flat-bottomed 24-well 
plates (Corning, Inc., Corning, NY, USA) in humidified 
atmosphere of 5% CO2 in air at 37°C with constant, slow 
motion (300 rpm/min), for 4 h. The choice of the incubation 
time was based on various data from the literature and our 
own experience [12]. We expected that it will be sufficient for 
stimulation of most of the studied genes. Furthermore, the 4 
hour-long incubation time was dictated by the fear that the 
response of the synovial membrane kept in vitro for longer 
times may depend not only on the stimulant used but also 
be influenced by factors released from synovial membrane 
cells or adjustment of the tissue to incubation conditions, i.e. 
to differences in oxygen tension in the joint and incubator. 
The SM from one knee joint served as the control to the 
SM from the opposite knee. The control SMs were cultured 
in RPMI (Gibco-BRL, Paisley, UK) with 0.1% bovine 
albumin (Sigma-Aldrich Chemie, Steinheim, Germany) 
and 1% Antibiotic/Antimycotic Solution (Sigma-Aldrich). 
Experimental SMs were incubated in the medium enriched 
with recombinant cytokines in concentration found in CIF. 
The following cytokines: bFGF (2.5 ng/mL) G-CSF (25 pg/
mL), M-CSF (60 pg/mL), (PromoKine, PromoCell GmbH, 
Heidelberg, Germany), TGFb1 (0.5 ng/mL) (Sigma-Aldrich) 
and IGF1 (2 ng/mL) (R & D Systems, Minneapolis, MN, 
USA) were used in following combinations: TGFb1/IGF1, 
TGFb1/IGF1/bFGF or G-CSF/M-CSF. After incubation the 
total RNA from synovial membrane cells was isolated and 
the expression of genes encoding HAS1, lubricin, collagen 
type I, aggrecan, versican, MMP3, TIMP1, IL-1b, IL-6, TNF 
and TGFb1 was examined. 
Total synovial membrane RNA isolation. RNA was isolated 
with NucleoSpin®RNA II kit (Macherey-Nagel, Duren, Ger-
many), according to manufacturer’s protocol. The quantity 
and quality of the isolated total RNA was evaluated spectro - 
161Growth factors and expression of ECM proteins in synovial cells
©Polish Society for Histochemistry and Cytochemistry
Folia Histochem Cytobiol. 2016
10.5603/FHC.a2016.0019
www.fhc.viamedica.pl
photometrically using ND-2000 — Spectrophotometer 
NanoDrop2000 with software for analysis of nucleic acids 
(Thermo Fisher Scientific, Wilmington, DE, USA).
Reverse transcription. Reverse transcription was performed 
using the High Capacity cDNA Reverse Transcription Kit 
(Applied Biosystems, Cheshire, UK), according to the man-
ufacturer’s protocol in Eppendorf Mastercycler gradient 
(10 min 25°C, 120 min 37°C, 5 sec 85°C). Briefly, 2 μL of 10× 
RT buffer, 0.8 μL of 25× dNTP Mix, 2 μL of 10× Random 
Primers, 1 μL of Multiscribe Reverse Transcriptase, 4.2 μL 
of nuclease-free water and 10 μL of mRNA (0.5 μg) per one 
reaction. cDNA samples were stored at –20°C.
Real-time PCR. Real-time PCR was performed in the 
ABI PRISM 7500 (Applied Biosystems) using 96-well 
optical plates. Each sample was run in triplicate and was 
supplied with an endogenous control (Rat GAPDH en-
dogenous control (VIC®/MGB Probe, NM_0170083). For 
gene expression analysis, the proper inventoried TaqMan 
expression assays was used (Rn00597231_m1 for HAS1, 
Rn01490812_m1 for lubricin, Rn01526721_m1 for collagen 
type I, Rn00573424_m1 for aggrecan, Rn00591740_m1 for 
MMP3, Rn 00587558_m1 for TIMP1, Rn99999017_m1 
for TNF, Rn01410330_m1 for IL-6 and Rn00572010_m1 
for TGFb). All probes were stained with FAM (Applied 
Biosystems). Reactions was run in 25 μL of volume with 
TaqMan Universal Master Mix, appropriate primer set, 
MGB probe and 50 ng of cDNA template. Universal ther-
mal conditions, 10 min at 95°C, 40 cycles of 15 sec at 95°C 
and 1 min at 60°C, were used. Data analysis was done with 
sequence detection software ver. 1.2 (Applied Biosystems). 
The amount of RNA transcript in SMs kept in the control 
medium was estimated by delta Ct. 
Statistical analysis. Data were analyzed by the Wilcoxon 
matched-pair test (Statistica software) [13]. A p-value < 0.05 
was considered to indicate a statistically significant differ-
ence. 
Results
Data presented in Figure 1 document that TGFb1/ 
/IGF1 stimulated expression of HAS1, lubricin, colla-
gen type I, aggrecan. TGFb1 inhibited the expression 
of MMP3 and TNF and had no effects on TIMP1 
and IL-6 expression. TGFb1/IGF1/bFGF stimulated 
the expression of HAS1, lubricin and TGFb1 and 
inhibited the expression of TNF. The combination 
of the latter three growth factors had no effect on 
the expression of collagen type I, aggrecan, MMP3, 
TIMP1 and IL-6. G-CSF/M-CSF, which due to their 
low concentration in CIF were used jointly, stimulated 
only the expression of aggrecan (Figure 1).
TGFb1, bFGF, and IGF1 applied individually 
exerted inhibitory effect on the expression of lubricin. 
Figure 1. The influence of growth factors on the mRNA level of genes encoding extracellular matrix proteins and cytoki-
nes in rat synovial membranes. The mRNA levels for hyaluronan synthase 1 (HAS1), extracellular matrix proteins, matrix 
metalloproteinase 3 (MMP3), tissue inhibitor of metalloproteinase 1 (TIMP1) and cytokines in the synovial membrane 
cells were measured by real-time PCR after 4 h of incubation with TGFb1/IGF1, TGFb1/IGF1/bFGF or G-CSF/M-CSF. 
Values are expressed as the means ± SE; n = 6 in each group. Relative expression was calculated against the reference 
gene, GAPDH. Analysis was conducted as a relative quantification study, using control synovial membrane gene expres-
sion as a calibrator (value 1). Statistically significant differences in the expression of particular genes in relation to control 
synovial membranes, according to the Wilcoxon matched-pair test at p < 0.05 are marked with asterisks. Abbreviations: 
TNF — tumor necrosis factor; IL-6 — interleukin-6; TGFb1 — transforming growth factor b1; IGF1 — insulin-like  
growth factor 1; bFGF — basic fibroblast growth factor.
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TGFb1 and bFGF inhibited expression of MMP3 
and bFGF inhibited also expression of aggrecan and 
TNF (Table 1).
Discussion
Stimulation of gene expression under influence of 
particular growth factors may depend on the reac-
tivity of particular cell types present in the synovial 
membrane [12]. Thus, the response of the studied 
genes may represent a summary of activity of several 
cell types. A precise comparison of gene expression in 
the rat synovial membrane with data for particular cell 
types presented by other authors is difficult due to the 
difference in the origin of the cells, their various mod-
ifications in culture, the differences in the period of 
observation and the dosage of the stimulating agents. 
With these limitations in mind, we have nevertheless 
attempted some comparisons to present our data in 
the more general context.
Hyaluronan synthases (HASs) are expressed by 
human fibroblast-like synoviocytes [14] and their 
expression is stimulated by TGFb1 [15]. TGFb1 
stimulated also hyaluronan synthesis in rat syno-
vial membrane [16]. On the other hand, TGFb1 
decreased the production of hyaluronan in mice 
epiphyseal growth plate but this production is 
stimulated by IGF1 [17]. In our present work the 
expression of HAS1 was not stimulated by TGFb or 
IGF1 acting alone, but both factors applied together 
exerted distinct stimulatory effect suggestive of cer-
tain synergism which, as far as we could establish, 
has not been observed previously.
Lubricin is produced by fibroblast-like synovi-
ocytes and chondrocytes [7, 18]. In the previous 
studies TGF-b1 stimulated secretory rate of lubricin 
by fibroblast-like synoviocytes [19] and accumulation 
of lubricin in superficial zone chondrocytes and syn-
oviocytes [20]. The discrepancies with the results of 
our study in which TGFb1, bFGF and IGF1 applied 
individually inhibited expression of lubricin while the 
effects of composition of TGFb1/IGF1 or TGFb1/ 
/bFGF/IGF1 were opposite may be probably ex-
plained by the fact that we have worked with the 
synovial membrane as a whole organ in which various 
secretory pathways could be activated. 
Collagen type I within synovial membrane is pro-
duced by synovial fibroblasts [21]. Both IGF1 [22] and 
TGFb1 [23] enhance collagen type I gene expression 
in different cell types such as smooth muscle cells [22] 
or fibroblasts, and Ito cells [23]. In our experiments 
TGFb1, bFGF and IGF1 used individually did not 
affect its expression but stimulation occurred only 
when both TGFb1 and IGF1 were added to the culture 
medium. It may be assumed that the exposition of syn-
ovial cells to individual factors that lasted 4 hours was 
too short to activate transcription, but their synergic 
action was effective. On the other hand, stimulatory 
effect of TGFb1/IGF1 was inhibited by the addition of 
bFGF. Inhibition of IGF1 anabolic action by bFGF was 
also observed in articular chondrocytes by dimethyl - 
methylene blue (DMMB) assay for proteoglycan 
production and DNA assay for measurements of cell 
numbers [24].
Aggrecan within joint tissues is produced by chon-
drocytes [25] and fibroblast-like synoviocytes [26]. 
Although IGF1 is thought to be the major stimulator 
of aggrecan synthesis by articular cartilage cells [27] 
we did not demonstrate this effect of IGF1 used at 
the concentration observed in cartilage interstitial 
fluid [10]. IGF1 and TGFb1 used together stimulat-
ed aggrecan expression. Similar synergistic action of 
both agents in increasing the expression of aggrecan 
mRNA was also observed in rat [28] and human [29] 
articular chondrocytes. bFGF inhibited expression of 
aggrecan, similarly as in earlier reports [30]. When 
bFGF was applied together with TGFb1 and IGF1 
the expression of aggrecan mRNA was at the level 
of control value. This observation is in accord with 
Table 1. The influence of growth factors on the mRNA 
level of genes encoding extracellular matrix proteins and 









HAS1 0.87 ± 0.06 0.96 ± 0.05 0.92 ± 0.04
Lubricin 0.57 ± 0.06* 0.64 ± 0.09* 0.79 ± 0.04*
Collagen1 0.81 ± 0.10 0.94 ± 0.15 0.76 ± 0.07
Aggrecan 1.83 ± 0.73 0.43 ± 0.11* 1.15 ± 0.16
MMP3 0.75 ± 0.05* 0.72 ± 0.04* 1.11 ± 0.06
TIMP1 0.82 ± 0.09 0.94 ± 0.05 1.02 ± 0.02
TNF 0.81 ± 0.09 0.60 ± 0.06* 1.25 ± 0.17
IL-6 1.03 ± 0.09 0.84 ± 0.07 1.14 ± 0.08
TGFb1 0.92 ± 0.04 1.06 ± 0.05 0.90 ± 0.05
The mRNA levels of cytokines and extracellular matrix proteins in rat 
synovial membrane was measured by real-time PCR after incubation 
for 4 h with TGFb1, bFGF or IGF1. Relative gene expression was 
calculated against the expression of the reference gene, GAPDH. 
Analysis was conducted as a relative quantification study, using control 
synovial membrane genes’ expression as a calibrator (value 1). Values 
are expressed as the means ± SE. *Statistically significant difference 
in the expression of a particular gene in relation to control, Wilcoxon 
matched-pair test, p < 0.05 (n = 6 in each group). Abbreviations: 
bFGF — basic fibroblast growth factor; HAS1 — hyaluronan synthase 
1; IGF1 — insulin-like growth factor 1; IL-6 — interleukin-6; MMP3 
— matrix metalloproteinase 3; TIMP1 — tissue inhibitor of metallo-
proteinase 1; TGFb1 — transforming growth factor b1; TNF — tumor 
necrosis factor.
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that of Loeser et al. [24] who found that the anabolic 
activity of IGF1 was significantly inhibited by bFGF. 
In our work, the strongest expression of aggrecan’s 
mRNA occurred after the exposition of synovial cells 
to G-CSF/M-CSF. This novel observation extends 
the findings on rat chondrocytes which demonstrated 
stimulation of aggrecan synthesis by GM-CSF [31] 
and M-CSF [32]. It has to be noted that GM-CSF and 
G-CSF being produced by synovial fibroblasts [33] 
may stimulate aggrecan production in an autocrine 
or paracrine manner.
MMP3 was shown to be produced in synovial mem-
brane by fibroblast-like synoviocytes [34], adipocytes [35], 
endothelial cells [36] and macrophages [37]. In the 
present study the expression of MMP3 mRNA was 
inhibited by TGFb1 and bFGF acting alone and 
TGFb1/IGF1 acting jointly while the combination of 
TGFb1/IGF1/bFGF had no effect. It is unexpected 
result, suggesting that IGF1 does not interfere with 
the action of TGFb1 but inhibits action of TGFb/ 
/bFGF. Similarly as in this work, TGFb1 inhibited 
also MMP3 expression in synovial membrane after 
longer exposition lasting 12 hours [12]. Contrary to 
our result, bFGF induced expression of MMP3 in 
periodontal ligament (PDL) cells [38].
TIMP1 is expressed in macrophages and mono-
cytes [39], fibroblast-like synoviocytes [40], en-
dothelial cells [36] and adipocytes [41]. TGFb1, in 
concentration 5 ng/mL, stimulated TIMP1 expression 
in human synovial lining cells isolated from synovi-
al membrane [40]. In our experiments the TIMP1 
expression was not changed by any of the studied 
factors, neither used individually or in combination, 
probably due to the too low concentration of the 
cytokines. Moreover, contrary to the other authors, 
who have studied the isolated populations of synovial 
lining cells, we worked with the synovium as a whole 
organ composed of several types of cells. 
TNF is produced by various cell types including 
macrophages [42] and adipose cells [43]. We showed 
that TNF expression was inhibited by bFGF, and 
combination of growth factors TGFb1/IGF1 and 
TGFb1/IGF1/bFGF. Although in this study TGFb1 
used individually at 2 ng/mL had no effect on the TNF 
mRNA level the concentration used was probably 
too low since in our previous work, when synovial 
membrane was incubated at 10 ng/mL TGFb1 for 12 
h, the expression of TNF mRNA was enhanced [12]. 
IL-6 can be produced by four main cell types of 
the synovial membrane [21, 42, 44, 45]. In our study 
none of the factors used, either individually or in 
combination, changed the expression of the IL-6 
gene. Contrary to that, in our previous study, when 
synovial membrane was incubated for 12 h at 10 ng/mL 
of TGFb1, IL-6 gene expression was enhanced [12]. 
TGF-b1 is expressed by the fibroblast-like syn-
oviocytes, endothelial cells [44], adipocytes [43] and 
macrophages [46] and can induce its own gene ex-
pression in fibroblasts [47], and other cell types [48]. 
In our study TGFb1, bFGF or IGF1 used individually 
did not significantly change TGFb1 expression, but it 
was raised by TGFb1/IGF1 and TGFb1/IGF1/bFGF. 
In our previous work TGFb1 used alone, stimulated 
its own expression, but the incubation lasted longer 
and the dose was higher [12]. 
The response of the studied genes may represent 
a resultant activity of all major cell types building the 
synovial membrane, i.e. highly specialized synovial 
fibroblasts, macrophages, epithelial cells and adipo-
cytes. Synovial membrane within joint cavity may be 
affected by several agents released by its cells and by 
articular cartilage. 
Studies on the reaction of the synovial membrane 
as a functional unit to growth factors gain additional 
perspective since the introduction of intraarticu-
lar platelet-rich plasma (PRP) administration as 
a stimulant for chondrogenesis [49]. Growth factors 
released from platelets may evoke various, and as 
yet difficult to predict, reactions of the synovial 
membrane cells. PRP contains i.a. TGFb1, IGF1 
and bFGF, the same factors which are present in 
CIF; thus results of the present work could probably 
be also useful for the characterization of synovial 
membrane response to PRP.
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